ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2248

Clinical Outcomes, Neuropathic Pain and Patient Satisfaction over a 15 Year Period Following Primary Tka: A Repeat-Cross-Sectional Analysis

Anne Lübbeke1, Matthieu Zingg2, Daniel Fritschy1, Pierre Hoffmeyer1 and Hermes Miozzari2, 1Orthopaedic Surgery, Geneva University Hospitals, Geneva, Switzerland, 2Orthopaedics, Geneva University Hospitals, Geneva, Switzerland

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: longitudinal studies, pain and patient outcomes, Total Knee Arthroplasty (TKA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects: Therapeutics

Session Type: Abstract Submissions (ACR)

Background/Purpose

Studies evaluating patient-reported long term outcomes (>10 years) after primary TKA are lacking. Moreover, variability in patient satisfaction after TKA has been reported for the short and mid term, but has not been investigated over the long term and in relation to presence or absence of neuropathic pain.

Our objective was to assess pain, function, general health, and patient satisfaction at short, mid and long term following primary TKA.

Methods

Patients eligible for this study were part of a prospective hospital-based cohort of all primary TKAs operated upon since March 1998. All patients operated in 2012, 2010, 2007, and 2004-1998, who were alive and still living in the area, received a postoperative questionnaire by mail between 2012 and 2013. We performed repeat cross-sectional analyses of pain, function, general health and patient satisfaction at the following time-points: prior to surgery, and 1, 2, 5, 9-11 and 12-15 years postoperative. Pain was evaluated with use of WOMAC and VAS score, neuropathic pain with DN4 (=neuropathic pain diagnostic questionnaire), function with WOMAC, general health with the SF-12, and satisfaction was evaluated with use of a five-item satisfaction rating.

Results

1451 TKAs were eligible (68.4% women, mean age 71 (±9) years, mean BMI 29.6 kg/m²). Of those, 1021 returned the questionnaire (response rate 70.4%). Their mean age was 71 years, mean BMI was 29.5 kg/m² and 67.8% were women. Mean values of pain, function and general health were clinically significantly higher (effect sizes 0.22-1.71) one year postoperative as compared to prior to surgery (see Table). For pain and satisfaction there was an ongoing clinically significant “improvement” between 1 and 2 years postoperative. Results remained similar between 2 and 10 years with minimally lower (effect size <0.2)  outcomes between 10 and 15 years. Neuropathic pain was reported in 12.4% preoperative, 14% at 1 year, 10% at 2 years and 5-7% 5-15 years after surgery. Its presence was significantly (p<0.001) associated with dissatisfaction.

Conclusion

Clinical outcomes and patient satisfaction were similar between 2 and 15 years after primary TKA. Neuropathic pain when present was strongly associated with dissatisfaction. 

 

Prior to surgery

n

1 yr. post surgery

n

2 yrs. post surgery

n

5 yrs. post surgery

n

10 yrs. post surgery

n

12-15 yrs. post surgery

n

WOMAC, mean, SD

 

 

 

 

 

 

 

 

 

 

 

 

   Pain

39.8 (±17.9)

785

72.2 (±22.1)

529

77.9 (±22.0)

111

82.3 (22.6)

100

78.8 (±23.6)

145

75.5 (±26.4)

136

   Function

43.7 (±19.3)

769

70.1 (±21.8)

526

68.1 (±22.7)

107

69.1 (±25.0)

102

69.8 (±26.4)

144

67.2 (±28.8)

136

VAS pain, mean, SD

5.9 (±1.8)

389

2.4 (±2.2)

522

2.0 (±2.3)

106

1.6 (2.4)

103

2.0 (±2.5)

138

2.0 (±2.5)

140

SF-12, mean, SD

 

 

 

 

 

 

 

 

 

 

 

 

   pcs

34.3 (±7.6)

777

40.4 (±8.8)

521

40.2 (±9.8)

106

39.8 (±10.5)

98

38.9 (±10.0)

136

37.5 (±9.9)

126

   mcs

44.9 (±11.2)

777

47.3 (±11.0)

521

47.9 (±10.3)

106

46.9 (±9.9)

98

47.5 (±11.2)

136

45.9 (±10.0)

126

DN4 score ≥ 4 (%)*

14 (12.4)

113

27 (14.4)

187

11 (10.3)

107

7 (6.9)

102

8 (5.8)

138

7 (5.1)

136

 

 

 

 

 

 

 

 

 

 

 

 

 

Satisfaction (%)

 

 

 

520

 

109

 

103

 

151

 

142

   Very satisfied

 

 

252 (48.5)

 

54 (49.5)

 

48 (46.6)

 

90 (59.6)

 

81 (57.0)

 

   Satisfied

 

 

157 (30.2)

 

39 (35.8)

 

39 (37.9)

 

42 (27.8)

 

37 (26.1)

 

   Somewhat

   satisfied

 

 

73 (14.0)

 

10 (9.2)

 

8 (7.8)

 

10 (6.6)

 

10 (7.0)

 

   Somewhat

   dissatisfied

 

 

15 (2.9)

 

2 (1.8)

 

4 (3.9)

 

2 (1.3)

 

5 (3.5)

 

   Dissatisfied

 

 

23 (4.4)

 

4 (3.7)

 

4 (3.9)

 

7 (4.6)

 

9 (6.3)

 

   DN4 score ≥ 4 in

   Dissatisfied (%)**

 

 

46.2 %

 

66.7%

 

 

 

17.9%***

 

 

 

*DN4 score = neuropathic pain diagnostic questionnaire; **among dissatisfied and somewhat dissatisfied patients taken together; ***5-15 years after surgery combined


Disclosure:

A. Lübbeke,
None;

M. Zingg,
None;

D. Fritschy,
None;

P. Hoffmeyer,

None,

9;

H. Miozzari,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-outcomes-neuropathic-pain-and-patient-satisfaction-over-a-15-year-period-following-primary-tka-a-repeat-cross-sectional-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology